clinical trial semaglutide New Science Suggests Improves CV Outcomes Beyond Weight Loss Semaglutide
Description
Multiple randomized controlled trials demonstrate that GLP-1 medications reduce body weight and improve cardiovascular outcomes in adults across age ranges, including seniors
Understanding how this treatment works, its approval status, and the experiences of other patients can help you make informed decisions
While semaglutide has shown great success in helping people lose weight and manage diabetes, some individuals have reported new or worsening symptoms of acid reflux or gastroesophageal reflux disease (GERD) after starting the medication
JAMA 282 , 15681575 (1999)
30066-X/asset/97fa9476-8bfa-4401-a0e6-bb6e0c8b8e77/main.assets/gr3_lrg.jpg)
It's just weight, mold, right
